Skip to main content
. 2023 Mar 25;102(5):605–611. doi: 10.1111/aogs.14550

TABLE 3.

Primary and secondary outcomes.

Outpatient group n = 282 Inpatient group n = 282 p‐value
Primary outcomes
Vaginal delivery, n (%) 238 (84.4) 243 (86.2) 0.55
Duration from hospital admission to delivery, hours, median (IQR) 12.8 (14.4) 20.7 (17.1) <0.001
Secondary outcomes
Cesarean delivery for fetal distress, n (%) 15 (5.3) 16 (5.7) 0.52
Cesarean delivery for dystocia, failed induction or maternal exhaustion, n (%) 26 (9.2) 21 (7.4) 0.63
Instrumental delivery for fetal distress, n (%) 17 (6.0) 19 (6.7) 0.64
Instrumental delivery for dystocia or maternal exhaustion, n (%) 11 (3.9) 17 (6.0) 0.45
Additional method of cervical ripening n (%) 72 (25.5) 94 (33.3) 0.42
Dinoprostone 16 (5.7) 59 (20.9) <0.001
Balloon catheter 58 (20.6) 45 (16.0) 0.16
Amniotomy 157 (55.7) 149 (52.8) 0.50
Oxytocin infusion 184 (65.2) 149 (52.8) 0.003
Total hospital stay, days, median (IQR) 2 (2) 3 (2) <0.001
Total dose misoprostol, μg, mean rank (IQR) 253 (175) 297 (120) <0.001
Induction start to birth, hours, median (IQR) 30.4 (19.2) 20.7 (17.1) <0.001
Apgar score <7 at 5 min n (%) 3 (1.1) 3 (1.1) 0.99
Umbilical artery cord pH <7.10, n (%) a 8 (4.8) 8 (4.8) 0.99
Admission to NICU, n (%) 15 (5.3) 10 (3.5) 0.31
Postpartum hemorrhage >1000 mL, n (%) b 31 (11.3) 234 (12.1) 0.77
Postpartum infection, n (%) 6 (2.1) 5 (1.8) 0.76
Perineal tears grade 3–4 9 (3.28) 13 (4.6) 0.38
a

Total number with analysis of cord artery pH: 166 outpatients and 167 inpatients.

b

Total number with documented blood loss: 275 outpatients and 275 inpatients.